Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial

Articles > Abstract · 2011

Authors: Suzan YALÇIN, RÜÇHAN USLU, F. DANE, U. YILMAZ, N. ZENGIN, E. BUYUKUNAL, S. BUYUKBERBER, C. CAMCI, O. SENCAN, S. KILICKAP

JOURNAL OF CLINICAL ONCOLOGY, Journal Indexed in SCI Expanded, International, 2011, vol 29, pp 3579-3579

DOI: 10.1200/jco.2011.29.15_suppl.3579

View details